CN Stock MarketDetailed Quotes

688087 Intco Recycling Resources

Watchlist
  • 28.86
  • +0.66+2.34%
Trading Jan 6 13:36 CST
5.40BMarket Cap23.05P/E (TTM)

Intco Recycling Resources Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Intco Recycling Resources Q3 2024 Earnings Date

Currency：CNYOct 31, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
796.88M
--
+15.43%
EPS
--
0.21
--
--
Analyst Rating
Strong Buy

Jan 6, 2025

Intco Recycling Resources Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 3.120B--
--2024/FY-- / 2.829B--
--2023/FY2.466B / 2.488B--
--2022/FY2.056B / 2.651B--
--2021/FY1.990B / 2.138B--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 3.120B--
--2024/FY-- / 2.829B--
--2023/FY2.466B / 2.488B--
--2022/FY2.056B / 2.651B--
--2021/FY1.990B / 2.138B--

Unlock Free Earnings Estimates

Intco Recycling Resources Earnings Reports

  • Yingke Renewable Resources Co., Ltd. Report for the third quarter of 2024

    Oct 30, 2024 12:00 ET

  • Yingke Renewable Resources Co., Ltd. Report for the third quarter of 2024

    Oct 30, 2024 12:00 ET

  • Yingke Renewable Resources Co., Ltd. 2024 Semi-Annual Report

    Aug 26, 2024 12:00 ET

  • Summary of the 2024 semi-annual report of Yingke Renewable Resources Co., Ltd.

    Aug 26, 2024 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jan 6, 2025

    Strong Buy

    • Strong Buy

      60.00%

    • Buy

      40.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Price
    % Chg

    No Data

    Investment Theme Energy-saving and Environmentally Friendly
    Energy-saving and Environmentally Friendly
    Intraday-0.85%
    Solid Waste Treatment
    Solid Waste Treatment
    Intraday-0.98%